1 / 8

Monoclonal Antibody Therapeutics Market - Size, Share, Outlook, and Analysis, 2018-2026

Monoclonal antibody therapeutics market is driven by active research and development of novel drugs and significant number of new drug launches and approval.

saairaj
Download Presentation

Monoclonal Antibody Therapeutics Market - Size, Share, Outlook, and Analysis, 2018-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Monoclonal Antibody Therapeutics Market - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026

  2. REPORT DESCRIPTION Monoclonal Antibody Therapeutics Market – Overview Frequent approvals of novel monoclonal antibodies and their launches in developed economies are expected to significantly drive monoclonal antibody therapeutics market growth over the forecast period. Key players in the market have gained regulatory approvals and have launched their therapies in the market. For instance, in 2015, the U.S. FDA approved Darzalex, developed by Johnson & Johnson for multiple myeloma. Similarly, in 2017, Roche was granted accelerated approval to TECENTRIQ (atezolizumab) from the U.S FDA for the treatment of people with locally advanced or metastatic urothelial carcinoma (mUC) who are not eligible for cisplatin chemotherapy. Moreover, approvals to several combination therapies are further expected to boost the global monoclonal antibody therapeutics market growth over the forecast period. For instance, in 2017, the U.S. FDA approved Darzalex (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients suffering from multiple myeloma. Moreover, different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD- L1.

  3. REPORT DESCRIPTION Monoclonal Antibody Therapeutics Market Taxonomy: By Source: Human Humanized Chimeric Others By Therapeutic Application: Oncology Autoimmune Diseases Infectious Diseases Hematological Disorders Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2403

  4. REPORT DESCRIPTION Monoclonal Antibody Therapeutics Market – Key Players Pfizer, Inc Novartis International AG Amgen, Inc Sanofi S.A Merck & Co GlaxoSmithKline Plc., F Hoffmann-La Roche Ltd AbbVie, Inc Eily, Lilly, and Company Bristol-Myers Squibb Company Get More Inf @ https://www.coherentmarketinsights.com/market-insight/monoclonal-antibody-therapeutics-market- 2403

  5. ABOUT COHERENT MARKET INSIGHTS Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH SYNDICATED RESEARCH INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES CONSULT STUDIES COUNTRY SPECIFIC STUDIES

  6. ABOUT CMI SECTOR COVERAGE CLINICAL DIAGNOSTIC BIOTECHNOLOGY HEALTHCARE IT MEDICAL IMAGING PHARMACEUTICAL MEDICAL DEVICES OUR CLIENTS  Global Leading Equipment and System Manufacturers  Component Providers and System Integrators  Distributors, Retailors and Value Added Resellers  Healthcare IT Solutions Developers  Marketing Consultancies and the Advertising Industry  Private and Government organization  Outsourcing Companies

  7. ABOUT US RESEARCH SOLUTIONS KEY STATS GLOBAL REPORTS FEASIBILITY STUDIES 100+ Insights Published Per Year COUNTRY ANALYSIS 150+ CONSULT PROJECTS Consulting Projects Till Date SURVEY RESEARCH EXCEL FORECAST DATABASE 125+ COMPETITIVE ASSESSMENT Clients Worldwide Per Year TECHNOLOGY SNIPPETS Analysts and Contract Consultants 110+ Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique —we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

More Related